Advertisement
Advertisement

HROW

HROW logo

Harrow, Inc. Common Stock

23.96
USD
+0.61
+2.61%
Apr 17, 15:59 UTC -4
Closed
exchange

After-Market

24.34

+0.38
+1.59%

Harrow, Inc. Common Stock Profile

About

Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.

Info & Links

CEO

Mark L. Baum

Headquarters

1A Burton Hills Blvd., Suite 200
Nashville, TN 37215, UNITED STATES

Sector

Medical

Auditor

Crowe LLP

Share holders

57

Employees

382

Harrow, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

867.79M

Enterprise Value

1.04B

Enterprise Value/EBITDA(ttm)

37.73

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

6.34

Price to Book(mrq)

18.55

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

74.58%

Operating Margin(ttm)

-16.60%

Profit Margin(ttm)

-12.72%

Return on Equity(ttm)

-45.57%

Return on Invested Capital(ttm)

-7.60%

Return on Assets(ttm)

-8.87%

Income Statement

Revenue(ttm)

199.61M

Revenue Per Share(ttm)

5.60

Gross Profit(ttm)

150.37M

EBITDA(ttm)3

27.56M

Net Income Available to Common(ttm)

-17.48M

Diluted EPS(ttm)

-0.94

Share Statistics

Beta (5Y Monthly)

0.69

52-Week Change

102.70%

S&P 500 52-Week Change

5.42%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

35.65M

Dividend Yield

0.00%

Float4

30.75M

% Held by Insiders

13.67%

% Held by Institutions

72.76%

Balance Sheet

Total Cash(mrq)

47.25M

Total Cash Per Share(mrq)

1.33

Total Debt(mrq)

219.54M

Total Debt/Equity(mrq)

316.81%

Current Ratio(mrq)

2.08%

Quick Ratio(mrq)

1.44%

Book Value Per Share(mrq)

1.95

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.62

Free Cash Flow(ytd)

-23.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement